Mastery EAQ Ch. 30

A  Somatropin

B  Octreotide

C  Desmopressin

D  Corticotropin

A  Desmopressin

B  Vasopressin

C  Octreotide

D  Somatropin

A  “You can take the dose immediately when you remember it.”

B  “If it is almost time for your next dose, take a double dose of the drug at that time.”

C  “Skip the missed dose and resume your usual dosage schedule.”

D  “You should consult your primary health care provider immediately.”

A  Cosyntropin

B  Vasopressin

C  Somatropin

D  Desmopressin

A  Abdominal stress

B  Bleeding gums

C  Vertigo

D  Drowsiness

A  “Heat the medicine before administration.”

B  “Do not administer the drug to the patient.”

C  “Keep the bottle in warm water before administration.”

D  “Shake the medication before administration.”

A  Monitor fluid status.

B  Encourage vigorous exercise.

C  Monitor blood glucose levels closely.

D  Evaluate the patient for limping.

A  Monitoring the patient in an intensive care unit

B  Obtaining liver and renal function tests

C  Administering the vasopressin intravenously

D  Co-administering carbamazepine

A  Limping

B  Excessive thirst

C  Abdominal cramps

D  Bleeding gums

A  Headache, Low urine output, Low blood pressure, Nausea

B  Nausea, Blood glucose elevation, Headache, Low blood pressure

C  Low blood pressure, Blood glucose elevation, Headache, Low urine output

D  Nausea, Blood glucose elevation, Headache, Low urine output

A  Vasopressin nasal spray

B  Somatropin intramuscular

C  Octreotide subcutaneous

D  Desmopressin intravenously

A  Electrocardiogram (ECG)

B  Blood glucose

C  Liver enzymes

D  Renal panel

A  Previous somatropin injection site tender to touch.

B  Radiology report identifies no fracture with closed growth plates.

C  Reports episodic muscle pain during the past year.

D  Growth percentile has increased from the previous annual physical.

A  Obtain baseline weight and height measurements

B  Review the frequency with the health care provider

C  Review current laboratory values for blood glucose

D  Calculate the dosage with the pharmacist or another nurse

A  Assess the patient for headaches

B  Notice increase in body temperature

C  Monitor for signs of infiltration

D  Inquire about abdominal discomfort

A  Weight gain, Edema of the extremities

B  Increased urination, Thirst

C  Elevated blood pressure, Weight gain

D  Edema of the extremities, Elevated blood pressure

A  Make a note of the fluid intake.

B  Watch the IV site closely for infiltration.

C  Measure the patient’s urine output regularly.

D  Assess for signs of dehydration.

A  Esophageal varices and a history of type 2 diabetes

B  Carcinoid tumor-secreting vasoactive intestinal peptide (VIP)

C  Small-bowel fistula and having an acute asthma attack

D  Acromegaly and a serum creatinine level of 5.0 mg/dL

A  1. Clear the nasal passages.
2. Prime the pump by pressing down four times.
3. Place the spray nozzle in the nostril.
4. Give half a spray in each nostril.
5. Monitor the level of drug left in the pump.
6. Replace the cap on the bottle.

B  1. Clear the nasal passages.
2. Prime the pump by pressing down four times.
3. Place the spray nozzle in the nostril.
4. Give half a spray in each nostril.
5. Replace the cap on the bottle.
6. Monitor the level of drug left in the pump.

C  1. Clear the nasal passages.
2. Give half a spray in each nostril.
3. Place the spray nozzle in the nostril.
4. Prime the pump by pressing down four times.
5. Replace the cap on the bottle.
6. Monitor the level of drug left in the pump.

D  1. Clear the nasal passages.
2. Prime the pump by pressing down four times.
3. Place the spray nozzle in the nostril.
4. Replace the cap on the bottle.
5. Give half a spray in each nostril.
6. Monitor the level of drug left in the pump.

A  Patient B: carcinoid tumor; taking ciprofloxacin

B  Patient D: VIP; severe diarrhea and flushing; renal impairment

C  Patient C: VIP; life-threatening hypotension; diarrhea and flushing

D  Patient A: esophageal varices; type 1 diabetes

A  Headache, Joint pain

B  Fatigue, Headache

C  Joint pain, Fatigue

D  Diarrhea, Flushing

A  The patient needs to adjust fluid intake.

B  A higher dose of medication is required for treatment.

C  The patient is stable and needs reassurance.

D  The medication is not effective for this condition.

A  Inhaling the medication into the airway

B  Priming the pump each week

C  Storing the pump at room temperature

D  Administering half the dose in each nostril

A  “Do you feel very thirsty lately?”
“How many times do you urinate in a day?”

B  “Is there any change in the color of your urine?”
“Is there any change in the color of your sputum?”

C  “Is there any change in the color of your sputum?”
“Do you have excessive bleeding due to minor injuries?”

D  “Do you have excessive bleeding due to minor injuries?”
“Is there any change in the color of your urine?”

A  Weight, Skin turgor, Visual acuity

B  Skin turgor, Height, Visual acuity

C  Motor skills, Visual acuity, Skin turgor

D  Height, Weight, Motor skills

A  Replacing the cap on the pump after the procedure

B  Pressing the pump once to spray a 10-mcg dose

C  Pressing down on the pump two times to prime it

D  Priming the nasal pump once a week

A  Hypercalciuria

B  Hypothyroidism

C  Hypertension

D  Hyperglycemia

A  “Apply the drug preparation topically to the nasal membranes.”

B  “Dilute the drug preparation before administration.”

C  “Shake the drug preparation thoroughly before use.”

D  “Inhale the drug preparation by spraying into the nostrils.”

A  Abundant, diluted urine

B  Loss of consciousness

C  Watery diarrhea

D  Oozing blood

A  Cachexia and closed growth plates

B  Human immunodeficiency virus (HIV) infection

C  Acute bronchitis with laryngitis

D  Bilateral metastatic breast cancer

A  An 8-year-old with a pituitary tumor

B  A 10-year-old of short stature who has severe asthma

C  A 17-year-old who is 5 feet tall

D  A 7-year-old diagnosed with growth hormone deficiency

A  Vasopressin and carbamazepine

B  Vasopressin and demeclocycline

C  Somatropin and glucocorticoids

D  Desmopressin and carbamazepine

A  Edema

B  Hypoglycemia

C  Heartburn

D  Seizures

A  Hyponatremia

B  Hyperglycemia

C  Orthostatic hypotension

D  Hypokalemia

A  Ciprofloxacin

B  Glucocorticoids

C  Fludrocortisone

D  Cyclosporine

A  Cardiovascular disease, Diabetes insipidus, Type I von Willebrand

B  Seizure, Asthma, Cardiovascular disease

C  Asthma, Diabetes insipidus, Type I von Willebrand

D  Diabetes insipidus, Seizure, Type I von Willebrand

A  Reduces weight loss

B  Decreases fluid retention

C  Reduces fat levels

D  Decreases growth

A  Improved tissue-building processes, Low blood sugar levels, Retention of potassium levels

B  Low blood sugar levels, Increased lipid mobilization, Retention of potassium levels

C  Low blood sugar levels, Retention of potassium levels, Increased retention of sodium

D  Increased lipid mobilization, Increased retention of sodium, Improved tissue-building processes

A  Norepinephrine

B  Carbamazepine

C  Thioridazine

D  Acetaminophen

A  Weight, Blood pressure, Blood glucose levels

B  Liver enzyme levels, Renal function studies, Weight

C  Renal function studies, Liver enzyme levels, Blood pressure

D  Liver enzyme levels, Blood glucose levels, Renal function studies

A  Arthralgia, Hypercalciuria, Constipation

B  Constipation, Malaise, Hypercalciuria

C  Dyspnea, Constipation, Hypercalciuria

D  Malaise, Dyspnea,

A  Hypotension

B  Scar formation

C  Inflammation

D  Edema

A  Reduces the effects of desmopressin

B  Produces an additive effect

C  Causes prolongation of QT interval

D  Enhances the effects of desmopressin

A  Octreotide

B  Desmopressin

C  Somatropin

D  Vasopressin

A  Somatropin

B  Octreotide

C  Desmopressin

D  Cosyntropin

A  Polyuria

B  Dehydration

C  Polydipsia

D  Headache

A  Thyroid hormone

B  Cosyntropin

C  Octreotide

D  Oxytocin

A  Ciprofloxacin

B  Cyclosporine

C  Carbamazepine

D  Demeclocycline

A  Blood glucose level

B  Uric acid level

C  Complete blood count result

D  Creatinine clearance test

A  Luteinizing hormone

B  Vasopressin

C  Desmopressin

D  Somatropin

A  Acromegaly

B  Polyuria

C  Hypopituitary dwarfism

D  Polydipsia

A  Cosyntropin

B  Oxytocin

C  Octreotide

D  Vasopressin

A  Choriomammotropin

B  Somatostatin

C  Somatropin

D  Somatolactin

A  Thyroxine, Aldosterone, Thyrotropin-releasing hormone (TRH)

B  Adrenocorticotropic hormone (ACTH), Aldosterone, Thyrotropin-releasing hormone (TRH)

C  Thyroxine, Thyroid-stimulating hormone (TSH), Thyrotropin-releasing hormone (TRH)

D  Growth hormone (GH), Thyroid-stimulating hormone (TSH), Adrenocorticotropic hormone (ACTH)

A  Increased serum albumin levels

B  Decreased adrenocorticotropic hormone levels

C  Increased urine specific gravity

D  Relief of pain